James V. Caruso
2022
In 2022, James V. Caruso earned a total compensation of $1.5M as President and Chief Executive Officer at Cellectar Biosciences, a 32% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $277,225 |
|---|---|
| Option Awards | $616,697 |
| Salary | $569,250 |
| Total | $1,463,172 |
Caruso received $616.7K in option awards, accounting for 42% of the total pay in 2022.
Caruso also received $277.2K in non-equity incentive plan and $569.3K in salary.
Rankings
In 2022, James V. Caruso's compensation ranked 2,273rd out of 5,760 executives tracked by ExecPay. In other words, Caruso earned more than 60.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,273 out of 5,760 | 61st |
Division Manufacturing | 1,232 out of 3,136 | 61st |
Major group Chemicals And Allied Products | 545 out of 1,422 | 62nd |
Industry group Drugs | 500 out of 1,323 | 62nd |
Industry Pharmaceutical Preparations | 364 out of 969 | 62nd |
Source: SEC filing on April 26, 2024.
Caruso's colleagues
We found two more compensation records of executives who worked with James V. Caruso at Cellectar Biosciences in 2022.
News
Cellectar Biosciences CEO James Caruso's 2023 pay jumps 34% to $2M
April 26, 2024
Cellectar Biosciences CEO James Caruso's 2021 pay jumps 112% to $2.2M
April 29, 2022
Cellectar Biosciences CEO James Caruso's 2020 pay rises 9% to $1M
May 13, 2021
Cellectar Biosciences CEO James Caruso's 2019 pay jumps 21% to $934K
April 28, 2020
Cellectar Biosciences CEO James Caruso's 2018 pay falls 23% to $770K
April 29, 2019